In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Siemens Molecular Imaging Inc.

Division of Siemens Healthineers AG/Siemens Medical Solutions USA Inc.
www.ctimi.com

Latest From Siemens Molecular Imaging Inc.

CMS Urged To Cover Beta Amyloid PET Scans For Alzheimer's, But Cautiously

Imaging stakeholders call for Medicare coverage of beta amyloid positron emission tomography scans to help diagnose and manage dementia patients, but clinical societies warn against using the technology as a screening tool for Alzheimer’s disease. CMS took comments through Nov. 8 on its ongoing national coverage analysis.

BioPharmaceutical Medical Device

CMS Urged To Cover Beta Amyloid PET Scans For Alzheimer's, But Cautiously

Imaging stakeholders call for Medicare coverage of beta amyloid positron emission tomography scans to help diagnose and manage dementia patients, but clinical societies warn against using the technology as a screening tool for Alzheimer’s disease. CMS took comments through Nov. 8 on its ongoing national coverage analysis.

Medical Device Reimbursement

Medicare Coverage Of PET Pharmaceutical Agents Needs Revamp, Industry Says

A broad range of stakeholders is asking CMS to remove national non-coverage language for newly approved radiopharmaceuticals used in positron emission tomography to allow speedier access to new tools for diagnosing Alzheimer’s and other diseases.

Medical Device BioPharmaceutical

Medicare Coverage Of PET Pharmaceutical Agents Needs Revamp, Industry Says

A broad range of stakeholders are asking CMS to remove national non-coverage language for newly approved radiopharmaceuticals used in positron emission tomography to allow speedier access to new tools for diagnosing Alzheimer’s and other diseases.

Medical Device BioPharmaceutical
See All

Company Information

  • Industry
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Therapeutic Areas
  • Alias(es)
  • CTI Inc.
  • CTI Molecular Imaging Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Siemens Healthineers AG
  • Senior Management
  • Ronald Nutt, PhD, Pres. & CEO
    David Gill, CFO
    Joesph C Sardano, SVP, Sales & Mktg.
  • Contact Info
  • Siemens Molecular Imaging Inc.
    Phone: (865) 218-2000
    810 Innovation Dr.
    Knoxville, TN 37932-2562
    USA
UsernamePublicRestriction

Register